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Syndecans are differentially expressed during
the course of aortic aneurysm formation
Jing Wen, MD,a Peiyi Wang, MS,a Sumona V. Smith, MD,a Carolyn A. Haller, PhD,a and
Elliot L. Chaikof, MD, PhD,a,b Atlanta, Ga
Background: The syndecan family of cell surface proteoglycans can bind and modulate the activity of a diverse group of
soluble and insoluble ligands, which have been shown tomodulate events relevant to acute tissue repair and chronic injury
responses. The expression of members of the syndecan family of heparan sulfate proteoglycans during the course of aortic
aneurysm formation has not been previously investigated. In this investigation, the spatiotemporal expression of
syndecan-1, -2, and -4 was characterized in a murine model of aneurysm formation.
Methods:ApoE-deficient mice were maintained on an atherogenic diet for 8 weeks with concurrent infusion of angiotensin
II (0.75 mg/kg/day SQ). The expression of syndecan-1, -2, and -4 at the site of aneurysm formation was characterized
by immunohistochemical staining and colocalization determined by double fluorescent immunostaining. Correlative
examination was performed on tissue specimens harvested from patients at the time of open aneurysm repair.
Results: In the aortic wall of age-matched, untreated mice, syndecan-4 was localized to the smooth muscle cells of the
media. However, neither syndecan-1 nor syndecan-2 could be detected. Within 1 week of initiating a high fat diet and
infusion of angiotensin II, syndecan-1 was abundantly expressed in infiltrating macrophages, predominantly localized to
the periadventitial aorta. The expression of macrophage-associated syndecan-1 was accentuated during the course of
aneurysm formation. As the aneurysm matured, syndecan-2 was abundantly expressed within the aortic thrombus and
heterogeneous syndecan-4 staining noted within the aortic media. Significantly, abundant syndecan-1 positive macro-
phages were observed in explanted human specimens.
Conclusions: Given the established functional properties of this family heparan sulfate proteoglycans, chronically
accelerated macrophage syndecan-1 shedding could generate a sustained proinflammatory, proteolytic, growth-
stimulating environment. As a component of a counterbalancing reparative process, cell surface syndecan-2 may
assist in TGF- mediated responses to limit the growth of abdominal aortic aneurysms. ( J Vasc Surg 2007;46:
1014-25.)
Clinical Relevance: Syndecans are ubiquitous heparan sulfate proteoglycans that modulate events relevant to acute tissue
repair and chronic injury responses, including cell migration and proliferation, cell-substrate interactions, and matrix
remodeling. Given these established functional properties, it is plausible that members of the syndecan family could play
an important role in the genesis of aortic aneurysms through regulation of the local inflammatory, proteolytic, and
growth-stimulating environment in the vascular wall.Systemic arterial hypertension is an independent and po-
tent risk factor for aneurysm formation1,2 and an enhance-
ment of both atherogenesis and aneurysm formation has been
recently noted in ApoE deficient mice after induction of
hypertension by the infusion of angiotensin II and/or norepi-
nephrine.3-7 The net effect of these changes in the microme-
chanical environment within the vessel wall is to increase the
expression of a variety of growth-stimulating and proinflam-
matory geneproducts. For example, sustainedhypertension in
vivo and cyclic stretch in vitro increases super oxide produc-
tion via NADH/NADPH oxidase, causes PDGF and
FGF-2 release, and increases the transcription of monocyte
chemoattractant protein-1 (MCP-1) and macrophage
colony-stimulating factor (MCSF).8-14 Through both au-
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1014tocrine and paracrine mechanisms, these factors contribute
to the altered growth-state of the arterial wall and help to
define the cellular and molecular mechanisms responsible
for the recruitment of inflammatory cells into sites of
chronic vascular wall injury. As a consequence of these
events, vascular smooth muscle cells and infiltrating mac-
rophages release matrix metalloproteinases (MMPs), par-
ticularly MMP-2 and MMP-9 that cause the destruction of
collagen and elastin with inevitable aneurysmal dilatation of
the aortic wall.15,16
The syndecans are a family of cell surface proteoglycans,
which along with the glypicans are the major source of cell
surface heparan sulfate (HS).17,18 Glypicans are not widely
expressed in the vascular wall and of the four known
members of the syndecan family (syndecan-1 through -4),
syndecan-3 is only expressed in neural tissue. Detailed
description of cell and tissue specific patterns of expression
can be found elsewhere.17 Notably, syndecans, through
their role as cell surface coreceptors, modulate events rele-
vant to acute tissue repair and chronic injury responses,
including cell migration and proliferation, cell-substrate
interactions, and matrix remodeling. Indeed, syndecan-1,
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group of soluble and insoluble ligands, such as extracellular
matrix components, including fibronectin and collagen,
growth factors, such as FGF-2, TGF-, and PDGF, CC and
CXC chemokines, and proteases, including MMP-1, 2, 9,
cathepsin G, and neutrophil elastase.18 Moreover, the ex-
pression of syndecans is highly regulated by soluble growth
factors, such as FGF-2, PDGF, and TGF- that are released
at sites of injury.19-22
Syndecans can modulate cell behavior through their
action as cell surface coreceptors and more recent investi-
gations have suggested that accelerated syndecan shedding
provides another mechanism for regulating local host re-
sponses to tissue injury. Although syndecans are constitu-
tively released from the cell surface as part of normal
receptor turnover, accelerated syndecan shedding is a reg-
ulated host response to tissue injury and shed syndecan
ectodomains have recently been identified as regulators of
inflammation.23 Indeed, agents that increase syndecan
shedding are released and act during acute wound repair.
For example, tissue injury is accompanied by cellular stress,
accumulation of plasma- and inflammatory cell-derived
proteases (eg, thrombin, plasmin, elastase, cathepsin G),
and release of growth factors (eg, EGF, HB-EGF, TGF-)
each of which accelerates syndecan shedding.24-27
In summary, syndecans display the capacity to modulate
proinflammatory, proteolytic, and growth-stimulating pro-
cesses relevant to vascular lesion formation but their role in
aneurysmal disease has yet to be examined. Therefore, in this
investigation we sought to determine the spatial and temporal
patterns of expression of syndecan-1, -2, and -4 in a murine
model of angiotensin II induced aortic aneurysm formation.
Selected findings were confirmed in explanted human aneu-
rysm wall tissue.
METHODS
Animal model. All experimental procedures were ap-
proved by the Institutional Animal Care and Use Commit-
tee and were in accordance with the Guide for the Care and
Use of Laboratory Animals (NIH). ApoE acts as a ligand
for the receptor-mediated clearance of chylomicrons,
VLDL, and HDL. As a consequence, mice lacking ApoE
have plasma cholesterol levels that are four to five times
normal and develop atherosclerotic lesions spontaneously,
even when fed a normal chow diet.28-30 Significantly, ath-
erosclerotic lesion development can be accelerated by a high-
fat, high-cholesterol diet and infusion of angiotensin II.3
The murine model of angiotensin-associated aortic aneu-
rysm is produced by subcutaneous administration of angio-
tensin II into ApoE-/- mice fed an atherogenic diet and has
been detailed elsewhere.3,4,7 Similar to human aneurysmal
disease, the propensity for the development of aneurysms is
much more common in males than females, as well as in
hyperlipidemic mice. The precipitating event appears to be
early medial macrophage accumulation, associated with
elastin degradation. The initial pronounced macrophage
response is followed by infiltration of other leukocyte pop-
ulations, medial degeneration, thrombus formation, andrupture. As in human disease, the activation of an inflam-
matory response is associated with stimulation of a proteo-
lytic cascade. In contrast with most human AAA, gross
dissections of the aortic wall are present that lead to prom-
inent vascular hematomas, which is clinically reminiscent
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Fig 1. Immunohistochemical staining of the aorta of ApoE-/- mice
prior to initiation of an atherogenic diet and infusion of angiotensin II.
A, Syndecan-1, 100x,B, syndecan-2, 40x, andC, syndecan-4, 400x.of acute aortic dissection.6
taine
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(C57BL/6 background), purchased from the Jackson Lab-
oratory (Bar Harbor, Me) received an atherogenic Paigen’s
diet (Research Diets, New Brunswick, NJ) along with
angiotensin II infusion at a dose of 0.75 mg/kg/day in
saline (Sigma, St. Louis, Mich or Bachem, King of Prussia,
Pa).3 The mice were fed ad libitum and had free access to
water. After 1, 4, or 8 weeks, mice were euthanized by CO2
inhalation, aortic tissues were harvested from six mice at
each time point for histological analysis, as described
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Fig 2. Immunohistochemical staining of the abdomi
atherogenic diet and infusion of angiotensin II. A, Mac
heads), D, syndecan-2, and E, syndecan-4. All images obbelow.Implantation of mini-osmotic pumps. Osmotic
minipumps (Model 1002 for 1 week infusion, model 2004
for 4 and 8 week infusions, Alza Scientific Products, Moun-
tain View, Calif), filled with angiotensin II solution, were
implanted into the subcutaneous space. The dosage of
angiotensin II for each mouse was determined individually
to ensure the delivery of 0.75 mg/kg/day.
Blood pressure measurement. Systolic blood pres-
sure before and after the implantation of miniosmotic
pumps was obtained from the mice using a noninvasive
rta of ApoE-/- mice one week after initiation of an
ge (arrowheads), B, neutrophil, C, syndecan-1 (arrow-
d at a magnification of 100x.D
B
nal ao
rophatail-cuff system (BP-2000 Blood Pressure Analysis Sys-
0x.
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103.9  1.5 mm Hg (n  60) at baseline, 141.0  20.7
mm Hg (n  10) at 1 week, 168.7  19.6 mm Hg (n 
10) at 4 weeks, and 181.3  14.8 mm Hg (n  6) at 8
weeks.
Histology and immunohistochemistry of murine
aortic aneurysm tissue. After animals were euthanized,
the heart and aorta were pressure-perfused with 0.9% NaCl
solution, as detailed elsewhere.3 Aortic tissue was har-
vested, embedded in OCT (Tissue-Tek; Miles Inc, Elkhart,
Ill), snap-frozen, and 5 m transverse cryosections pre-
pared. For histological analysis, sections were fixed in 10%
formalin and stained with hematoxylin and eosin. For im-
munohistochemical analysis, sections were fixed in cold
acetone, blocked with 10% sera from the species used to
generate the secondary antibody. Immunocytochemical
staining was performed to identify syndecan-1, -2, and -4,
macrophages, and neutrophils. At least two slides, contain-
ing 15 tissue sections, from each of six animals at each time
point were examined for each cell type. The following
reagents were used: goat anti-syndecan 1 antibody (N-18,
Santa Cruz Biotech, Santa Cruz, Calif; 1:50 dilution), goat
anti-syndecan-2 polyclonal antibody, T-17, Santa Cruz Bio-
tech (sc-9494), 1:100 dilution), goat anti-syndecan 4 anti-
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Fig 3. Immunohistochemical staining of the abdominal
diet and infusion of angiotensin II. A, Macrophage (arr
syndecan-4. All images obtained at a magnification of 20body (N-19, Santa Cruz Biotech; 1:100 dilution), rat anti-mouse Mac3 antibody (BD Pharmingen, San Diego, Calif;
0.625 g/mL) for macrophages, and rat anti-neutrophil
monoclonal antibody (NIMR-R14, abcam ab2557, 1:10
dilution). Negative controls with goat or rat IgG were
prepared for each specimen. Sections were then incubated
with biotinylated secondary antibodies (Vector Labs, Bur-
lingame, Calif) followed by streptavidin-alkaline phospha-
tase (Vector labs, 1:500 dilution). Vector Red substrate kit
I (Vector labs) was used as a substrate for alkaline phospha-
tases. Nuclei were visualized by counterstaining with hema-
toxylin.
To confirm colocalization of syndecan-1 with macro-
phages, double fluorescent immunostaining was per-
formed. Sections were first stained with anti-syndecan 1
antibody (N-18, Santa Cruz Biotech, 1:50 dilution) fol-
lowed by biotinylated secondary antibody and fluorescein
conjugated streptavidin (Vector Labs, 7.5 g/mL). To
detect macrophages, the sections were then incubated with
anti-Mac3 antibody (BD Pharmingen, 1:50 dilution) fol-
lowed by Alexa 594 conjugated secondary antibody (Mo-
lecular Probes, Eugene, Ore). Nuclei were visualized by
DAPI staining.
Histology and immunohistochemistry of human
aortic tissue. Specimens consisting of human aortic aneu-
 
 
of ApoE-/- mice 1 week after initiation of an atherogenic
ds), B, neutrophil, C, syndecan-1 (arrowheads), and D,B
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aorta
owhearysm wall were collected at Emory University Hospital
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Fig 4. Immunohistochemical staining of the abdominal aorta in ApoE-/- mice four weeks after initiation of an
atherogenic diet and infusion of angiotensin II. A, Macrophage 40x, B, macrophage 100x, C, neutrophil 40x
(arrowhead), and D, neutrophil 100x (arrowhead).D
 C 
 B  A 
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Fig 5. Immunohistochemical staining of the abdominal aorta of ApoE-/- mice 4 weeks after initiation of an
atherogenic diet and infusion of angiotensin II. A, Syndecan-1 40x (arrowheads), B, syndecan-1 (arrowheads), 100x,
C, syndecan-2, 40x, and D, syndecan-2, 100x (arrowhead, asterisk).
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10% formalin overnight and then processed in a paraffin
block. Five m thick serial sections were analyzed with
hematoxylin, eosin (Richard-Allan Scientific), Verhoeff-
Van Gieson (SigmaHT25-A). Immunocytochemical stain-
ing was performed to identify syndecan-1 and macro-
phages. Fifteen tissue sections from each of five tissue
samples were examined. The following antibodies were
used: monoclonal mouse anti-human CD68 (Clone PG-
M1, Dako) at 1:100 dilution for macrophage identifica-
tion; monoclonal syndecan-1(DL 101; Santa Cruz) at
1:100 dilution for syndecan-1 identification. Mouse IgG1,
kappa (M9035, Sigma) for negative control. The avidin-
biotin complex (ABC) method was used for staining. After
deparaffinized and rehydrated, sections were incubated in
water bath for 30 minutes at 95°C with target retrieval
solution (S1700, Dako) for antigen retrieval. Sections were
blocked with avidin and biotin blocking solutions (Dako,
X0590) and 10% goat serum. The sections were incubated
with primary antibodies for 60 minutes at room tempera-
ture, washed, and incubated for 30 minutes with a biotin-
ylated goat anti-mouse IgG (1:1500) secondary antibody.
After washing, the slides were incubated with streptavidin-
HRP (Dako, K0679) for 30 minutes, then DAB substrate
solution (Dako, K0679) was added yielded a brown prod-
uct on positive cells. Slides were counterstained with a
hematoxylin and mounted with xylene-based mounting
medium (Richard-Allan Scientific).
RESULTS
Syndecan-1 is an early marker of subsequent suprare-
nal aortic aneurysm formation. Immunohistochemical
staining of the aorta of ApoE-/- mice prior to initiation of
an atherogenic diet and infusion of angiotensin II did not
reveal the expression of syndecan-1 or -2 within the wall of
the abdominal aorta. In contrast, syndecan-4 is constitu-
tively expressed by smooth muscle cells in the media (Fig
1). As has been previously reported,4 within 1 week after
initiation of an atherogenic diet and infusion of angiotensin
II, macrophages infiltrate the periadventitial space of the
suprarenal abdominal aorta with some staining evident
within the media of the aortic wall (Figs 2 and 3). This early
inflammatory response was also characterized by the pres-
ence of focal neutrophil infiltrates in the periadvential area.
Syndecan-2 expression was not evident, while syndecan-4
staining of the media was unchanged. Notably, syndecan-1
expression was observed in the periadvential space in asso-
ciation with macrophage infiltration.
Syndecan-2 is expressed within the intramural throm-
bus of mature aortic aneurysms. Four weeks after initiation
of an atherogenic diet and angiotensin II infusion, aortic
aneurysms were present in the suprarenal aorta with mor-
tality due to ruptured aneurysms occurring in 30% of
mice. Consistent with prior reports, thinning and fragmen-
tation of the elastic fibers with disruption of the media and
intramural hematoma was evident consistent with initial
aortic dissection and subsequent aneurysm formation.6The inflammatory response was most intense within theadventitia with a predominance of macrophages and more
discrete regions of neutrophil infiltration (Fig 4). Immuno-
histochemical staining revealed persistent expression of
syndecan-1 in the adventitia at the site of the primary
inflammatory response and syndecan-4 in the media.
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Fig 6. Immunohistochemical staining of the abdominal aorta of
ApoE -/- mice four weeks after initiation of an atherogenic diet and
infusion of angiotensin II. A,Macrophage, B, syndecan-1, and C,
syndecan-4. All images were acquired at a magnification of 100x.Though not previously noted, syndecan-2 expression was
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6). Immunofluorescence staining confirmed colocalization
of syndecan-1 and Mac3, consistent with the notion that
the source of syndecan-1 in the periadvential aorta was
likely infiltrating macrophages (Fig 7).
Syndecan-4 is expressed in a spatially heteroge-
neous pattern within the media of aortic aneurysms.
The presence of macrophages persisted in specimens exam-
ined eight weeks after initiation of an atherogenic diet and
angiotensin II infusion (Figs 8 and 9). Syndecan-1 was
readily observed at sites of macrophage infiltration. Synde-
can-4 was present within the media except at obvious sites
of medial disruption. Atherosclerotic lesions, not previ-
ously observed in the 4-week group, were present within
the aortic aneurysm. Of note, syndecan-1 andmacrophages
were present within the lipid core of the atherosclerotic
lesion. Syndecan-4 staining was heterogeneous in the me-
dia, likely as a consequence of smooth muscle cell loss. Of
note, syndecan-4 expression was observed within the fi-
brous cap of the atherosclerotic lesion, though syndecan-2
staining was not detected either within the lipid core or the
fibrous cap.
Syndecan-1 positive macrophages are found within
the wall of human aortic aneurysms. Correlative immu-
nohistochemical staining was performed on the aortic wall
harvested from five patients at the time of open aneurysm
repair. Significantly, infiltration of syndecan-1 positive
Fig 7. Immunofluorescence staining of the abdominal a
diet and infusion of angiotensin II. A, Syndecan-1, B,
D, macrophage, syndecan-1, and DAPI.macrophages into the aortic wall was observed in all speci-mens. Representative images from two patients are shown
(Figs 10 and 11).
DISCUSSION
Although the etiology of aortic aneurysm formation
remains unclear, aneurysms are probably initiated by re-
cruitment of leukocytes into the aortic media as part of an
innate inflammatory response. In particular, macrophage
infiltration leads to the production of proinflammatory
cytokines,31,32 prostanoids,33,34 as well as reactive oxygen
species.35 Moreover, macrophages are the principle source
of MMPs, plasminogen activators, and cathepsins all of
which may contribute to elastin and collagen proteoly-
sis.36-38 Although medial smooth muscle cells in the dam-
aged aorta might otherwise promote structural repair, re-
sponses of this cell population are limited by induced
senescence and apoptosis.39,40
ApoE deficient mice develop aneurysms of the suprare-
nal aorta when fed an atherogenic diet and receiving a
continuous infusion of angiotensin II. Significantly, angio-
tensin II exerts several potential effects that may lead to
AAA formation, including a direct increase in arterial blood
pressure, stimulation of monocyte recruitment,41,42 activa-
tion of macrophages,43 and enhanced oxidative stress. Prior
studies have demonstrated that angiotensin II provokes a
marked pro-inflammatory response in the perimedial area,
manifest as an accumulation of macrophages at the external
f ApoE-/- mice 4 weeks after initiation of an atherogenic
rophage, C, macrophage, syndecan-1, and DAPI, andorta o
macelastic lamina with stimulation of a proteolytic cascade.
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tions of the aorta with intramural hematoma. At late stages
of the disease, large atherosclerotic lesions were noted
within the lumen of the aneurysm. The role of the uroki-
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Fig 8. Immunohistochemical staining of the abdominal aorta of
ApoE-/- mice 8 weeks after initiation of an atherogenic diet and
infusion of angiotensin II. A, Macrophage, B, syndecan-1, and
C, syndecan-4. All images were acquired at a magnification of
100x.nase pathway and MMPs in this animal model has beenconfirmed by the reduced incidence of AAAs in mice defi-
cient in urokinase or treated with the broad-spectrum
MMP inhibitor, doxycycline.
The expression of members of the syndecan family of
heparan sulfate proteoglycans during the course of AAA
formation has not been previously investigated. We noted
the presence of syndecan-4 in the native aortic wall, which
was localized to smooth muscle cells of the media, but
neither syndecan-1 nor syndecan-2 could be detected.
Within 1 week of initiating hyperlipidemia and infusion of
angiotensin II, syndecan-1 was abundantly expressed in
association with infiltrating macrophages, predominantly
localized to the periadventitial aorta. The syndecan-1 re-
sponse was accentuated during the course of AAA forma-
tion and our studies have confirmed that it is also abun-
dantly expressed in human aneurysm tissue, as well. As the
murine aneurysms matured, syndecan-2 was abundantly
expressed within the aortic thrombus and syndecan-4 ex-
pression became notably inhomogeneous within the aortic
media. The heterogeneity of syndecan-4 staining in the
aortic media of AAA is likely a consequence of the loss of
smooth muscle cells.
Syndecan-1 displays both heparan and chondroitin sul-
fate side chains and its expression is highly regulated in
tissues. For example, syndecan-1 is expressed in the embry-
onic mesenchyme of the lung, kidney and limb, but cannot
be detected in differentiated skeletal or cardiac muscle.44
The extracellular domain of syndecan-1 binds to bFGF
and many ECM proteins, including fibrillar collagens (col-
lagen type I, III, V), fibronectin, thrombospondin, and
tenascin.45 Kiefer et al46 have shown that syndecan-1 can
bind to bFGF via its heparan sulfate chains and Numa et
al47 demonstrated that over-expression of syndecan-1 in a
renal epithelial cell line results in a higher cellular growth
rate. While syndecan-1 mRNA is activated in balloon-
injured arteries48 and syndecans released from the cell
membrane appear to enhance SMCmigration in vitro,49 its
role in vascular lesion formation remains unclear.
It has been recently established that accelerated synde-
can shedding is a regulated host response to tissue injury
and shed syndecan ectodomains have recently been identi-
fied as regulators of inflammation. Shed syndecan-1 retains
its ligand binding activities, primarily through the heparan
sulfate (HS) and chondrotin sulfate (CS) glycosaminogly-
cans attached to the core protein and, as a consequence,
soluble syndecans are capable of exerting a significant bio-
logical effect. For example, syndecan-1 ectodomains have
been found in dermal wound fluids of patients and in
tracheal fluids of infants on chronic mechanical ventilatory
support.18,27 Syndecan ectodomains derived from human
dermal wounds bind the major inflammation-associated
proteases, neutrophil elastase and cathepsin G.27 Syndecan
binding reduces the affinity of these proteases for their
physiological inhibitors, the plasma-derived serpins 1-
anti-proteinase and 1-anti-chymotrypsin, with a com-
mensurate increase in protease activity. In support of these
observations, Bernfield and colleagues50 generated a
mousemodel in which syndecan-1 was overexpressed in the
were
, 20x.
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associated with increased proteolytic activity. Once shed,
syndecans are also capable of sequestering heparin binding
growth factors, such as FGF-2, within the extracellular
matrix, protecting these factors from heat, pH, and pro-
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Fig 9. Immunohistochemical staining of the abdomi
atherogenic diet and infusion of angiotensin II. A,
C, syndecan-4, and D, syndecan-2 (asterisk). All images
Fig 10. Immunohistochemical staining of human abdo
of human aortic wall (4x). B, Macrophage (anti-CD68)tease related degradation mechanisms. After heparanaseinduced HS cleavage, these heparin binding proteins are
then able to interact with cell bound receptors. In this
regard, Kato et al51 demonstrated that human wound
fluid contains physiologically significant concentrations of
mitogenically active HS fragments. It is also likely that
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*
orta of ApoE-/- mice 8 weeks after initiation of an
crophage (arrowheads), B, syndecan-1 (arrowheads),
acquired at a magnification of 40x.
l aortic aneurysm wall. A, Verhoeff Van Gieson staining
C, Syndecan-1, 20x. B
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Maminasyndecans are capable of sequestering a variety of heparin-
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within the extracellular matrix. Thus, while the role of
syndecan shedding in vascular lesion formation remains
speculative, it is possible that the expression and shedding
of syndecan-1 by infiltrating macrophages potentiates the
early inflammatory response, as well as the proteolytic
environment that leads to matrix degradation and AAA
formation.
Significantly, recent studies have demonstrated that
syndecan-2 interacts with matrix proteins such as laminin52
and fibronectin,53 and its cytoplasmic V region controls
matrix assembly at the cell surface.54 In addition to playing
a role in augmenting integrin-mediated matrix assembly
and, specifically, the assembly of both fibronectin and
laminin matrices, Klass and Woods have reported that
syndecan-2 can bind and increase signaling of Transform-
ing Growth Factor- (TGF- ), as well as regulate the
levels of TGF-  receptors.55,56 Specifically, syndecan-2
expression can increase the levels of type I and II TGF-
receptors, while reducing levels of type III TGF- recep-
tor, betaglycan. In this regard, TGF-1 is a multipotent
cytokine that induces expression of fibrillar collagen
and elastin,57,58 downregulates inflammation,59,60 pro-
motes VSMC growth61,62 and differentiation and inhib-
its MMP-dependent proteolysis.63,64 Moreover, recent
investigations have demonstrated that experimental an-
eurysms respond to TGF- 1 by a downregulation of
proteolysis and aortic enlargement. Thus, increased ex-
pression of syndecan-2 within the aortic aneurysm is
consistent with a reparative response to limit vascular
wall destruction.
In summary, syndecan expression within the aortic
wall is spatially and temporally regulated during the
course of experimental aneurysm formation. Given the
established functional properties of this family heparan
sulfate proteoglycans, it is plausible that chronically accel-
erated syndecan-1 shedding could potentiate vascular wall
Fig 11. Immunohistochemical staining of human abdom
B, Syndecan-1, 20x.lesion formation by promoting the generation of a sus-tained pro-inflammatory, proteolytic, growth-stimulating
environment. As a component of a counterbalancing repar-
ative process, cell surface syndecan-2 may assist in TGF- 
mediated responses to limit the growth of abdominal aortic
aneurysms.
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